Jazz Pharmaceuticals Overview

  • Founded
  • 2003
Founded
  • Status
  • Public
  • Employees
  • 1,620
Employees
  • Stock Symbol
  • JAZZ
Stock Symbol
  • Investments
  • 12
  • Share Price
  • $143.13
  • (As of Tuesday Closing)

Jazz Pharmaceuticals General Information

Description

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and indications in neuroscience and hematology-oncology. Jazz's product portfolio includes its lead drug, Xyrem, for narcolepsy, Sunosi for improving wakefulness in patients with excessive daytime sleepiness, Defitelio for severe veno-occlusive disease after stem cell transplant, Vyxeos for acute myeloid leukemia, and Zepzelca for small cell lung cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • Waterloo Exchange
  • Waterloo Road
  • Dublin 4
  • Ireland
+353 (01) 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Jazz Pharmaceuticals Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$143.13 $140.71 $86.88 - $158.98 $7.97B 55.5M 744K $3.20

Jazz Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 8,471,847 9,144,316 8,007,415 9,199,632
Revenue 2,279,790 2,161,761 1,890,922 1,618,693
EBITDA 645,963 896,719 823,269 684,027
Net Income 179,194 523,367 447,098 487,848
Total Assets 6,291,958 5,538,897 5,203,491 5,123,672
Total Debt 2,242,687 1,771,211 1,596,412 1,581,038
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Jazz Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jazz Pharmaceuticals‘s full profile, request access.

Request a free trial

Jazz Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorde
Pharmaceuticals
Dublin, Ireland
1,620 As of 2019
00.000
00000000000 00.000

00000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
000000000000000
Tarrytown, NY
0000 As of 0000
00000
00000000000 00000

000000 0

e et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000 00000000
San Jose, CA
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jazz Pharmaceuticals Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY 0000 00000 00000000000 00000
000000 0000 Angel-Backed San Jose, CA 0000 000000000 - 0000
000000000 00000000 Formerly VC-backed Stoughton, MA 000 00000 00000000000 00000
00000 Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
00000000 000000000 Venture Capital-Backed Boston, MA 000 00.000 000000000 00.000
You’re viewing 5 of 10 competitors. Get the full list »

Jazz Pharmaceuticals Executive Team (36)

Name Title Board Seat Contact Info
Bruce Cozadd Chief Executive Officer & Chairman
Daniel Swisher Jr. Chief Operating Officer, Operations & President
Renée Galá Executive Vice President & Chief Financial Officer
Heidi Manna Senior Vice President & Chief Human Resources Officer
Michael Miller Executive Vice President
You’re viewing 5 of 36 executive team members. Get the full list »

Jazz Pharmaceuticals Board Members (25)

Name Representing Role Since
Anne O'Riordan Jazz Pharmaceuticals Board Member 000 0000
Bruce Cozadd Jazz Pharmaceuticals Chief Executive Officer & Chairman 000 0000
Catherine Sohn Self Board Member 000 0000
Elmar Schnee Self Board Member 000 0000
Heather McSharry Self Board Member 000 0000
You’re viewing 5 of 25 board members. Get the full list »

Jazz Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jazz Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Jazz Pharmaceuticals‘s full profile, request access.

Request a free trial

Jazz Pharmaceuticals Investments & Acquisitions (12)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 000000 26-Oct-2020 000000000 00000 00 0000 Buildings and Property
000000 12-Aug-2019 000000000000000000 00000 Pharmaceuticals 000000 0000000 00
0000 000000 (00000 10-Jul-2019 000000000 00000 00 00000 Buildings and Property 000000 0000000 00
00000 24-Apr-2019 00000 00000 00 00.00 Monitoring Equipment 000 00000 00
Celator Pharmaceuticals 11-Jul-2016 Merger/Acquisition 00.00 Pharmaceuticals 00000000 0000000-000000
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

Jazz Pharmaceuticals Subsidiaries (2)

Company Name Industry Location Founded
Cavion Pharmaceuticals Charlottesville, VA 2002
0000000 Pharmaceuticals Villa Guardia, Italy 0000
To view Jazz Pharmaceuticals’s complete subsidiaries history, request access »

Jazz Pharmaceuticals Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000 12-Jun-2012 000000000000000000 00000 Completed
  • 0000 0000000000000
Prialt 05-May-2010 Merger/Acquisition Completed
To view Jazz Pharmaceuticals’s complete exits history, request access »